Evidence map›Paper›PMID 38312164›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2024

Crystal structure of [1,3-bis-(2,4,6-tri-methyl-phen-yl)imidazolidin-2-yl-idene]di-chlorido-(2-{[(2-methoxyeth-yl)(meth-yl)amino]-meth-yl}benzyl-idene)ruth-en-ium.

Gunay Z Mammadova, Zeliha Atioğlu, Mehmet Akkurt, Mikhail S Grigoriev, Nikita S Volchkov, Asmet N Azizova, Ajaya Bhattarai, Alexandra S Antonova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gunay Z MammadovaOrganic Chemistry Department, Baku State University, Z. Xalilov Str. 23, Az 1148 Baku, Azerbaijan.
Zeliha AtioğluDepartment of Aircraft Electrics and Electronics, School of Applied Sciences, Cappadocia University, Mustafapaşa, 50420 Ürgüp, Nevşehir, Türkiye.
Mehmet AkkurtDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Türkiye.ORCID https://orcid.org/0000-0003-2421-0929
Mikhail S GrigorievFrumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, Leninsky pr. 31, bld. 4, Moscow 119071, Russian Federation.ORCID https://orcid.org/0000-0002-6363-5535
Nikita S VolchkovOrganic Chemistry Department, Faculty of Science, RUDN University, Miklukho-Maklaya St., 6, Moscow 117198, Russian Federation.
Asmet N AzizovaDepartment of Synthesis of Biologically Active Compounds, Scientific Research Center, Azerbaijan Medical University, Samed Vurgun St. 167, Az 1022 Baku, Azerbaijan.
Ajaya BhattaraiDepartment of Chemistry, M.M.A.M.C (Tribhuvan University) Biratnagar, Nepal.ORCID https://orcid.org/0000-0002-2648-4686
Alexandra S AntonovaOrganic Chemistry Department, Faculty of Science, RUDN University, Miklukho-Maklaya St., 6, Moscow 117198, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compound, [RuCl

Indexed as

crystal structureHoveyda–Grubbs catalystolefin metathesisruthenium catalyst

Identifiers

PMID38312164
PMCPMC10833371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.